Company: DAWN
Filing Date: 2025-11-04
Form Type: 10-Q
Source: 0001193125-25-264649
Chunk: 131

Company: Day One Biopharmaceuticals, Inc.
Filing Date: 2025-11-04
Form: 10-Q
Item: Item 8
Chunk 131
---
Operating segments are defined as components of an entity about which separate discrete information is available for evaluation by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. The Company views its operations and manages its business in one operating segment.Concentration of Credit Risk and Other Risks and UncertaintiesFinancial instruments that subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, short-term investments, and accounts receivable. Amounts on deposit may at times exceed federally insured limits. The Company is exposed to credit risk in the event of default by the financial institutions holding its cash, cash equivalents and short-term investments that are recorded on its balance sheet. Per policy, the Company mitigates its risk by investing in high-grade instruments and limiting the concentration in any one non-United States government or government backed issuer, which limits its exposure. The Company has not experienced any losses on its cash, cash equivalents and short-term investments.
For the three months ended September 30, 2025, two individual customers accounted for 98.6% of total net product revenue, with these individual customers representing 74.0% and 24.6% of the Company's total net product revenue. For the nine months ended September 30, 2025, two individual customers accounted for 98.3% of total net product revenue, with these individual customers representing 66.4% and 31.9% of the Company's total net product revenue. As of September 30, 2025, two customers accounted for 91.7% of the accounts receivable balance, with these individual customers representing 68.5% and 23.2% of the accounts receivable balance. No other individual customers account for more than 10.0% of net product revenue or accounts receivable. The Company monitors the financial condition of its customers so that it can appropriately respond to